Side Effects of ocrelizumab injection: A Synthesis of Findings from 6 Studies

  1. Home
  2. Side Effects of ocrelizumab injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of ocrelizumab injection: A Synthesis of Findings from 6 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of ocrelizumab injection: A Synthesis of Findings from 6 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Ocrelizumab is a monoclonal antibody that has been shown to be effective in treating multiple sclerosis (MS). 1 A study found that ocrelizumab was clinically effective and well-tolerated, with manageable side effects. However, there is limited data on adverse events in everyday practice. 1 This study aimed to investigate the short-term tolerability of ocrelizumab in a "real-world" setting.

Reasons for side effects

Ocrelizumab works by suppressing the activity of immune cells, which helps slow the progression of MS symptoms. However, suppressing the immune system can increase the risk of infections and other side effects.

Common Side Effects

Infections

Ocrelizumab can increase the risk of infections because it suppresses the immune system. 1 , 3 These studies have shown that the incidence of infections is higher after ocrelizumab administration.

Other side effects

Side effects that may occur after ocrelizumab administration have been reported in studies such as 1 , 3 , 2 .

Side Effect Management

Infection Management

To reduce the risk of infection, it is important to take infection control measures such as hand washing, gargling, and getting enough sleep while taking ocrelizumab. 1

Side effect management

If you experience side effects, consult your doctor for appropriate treatment. 1

Comparison of Studies

Commonalities

Multiple studies have shown that ocrelizumab is effective in treating MS. 1 , 6 , 5 These studies found that ocrelizumab was clinically effective and well-tolerated, with manageable side effects.

Differences

The side effects that may occur after ocrelizumab administration vary from study to study. 1 , 3 , 2 These studies have reported various side effects such as infections, liver dysfunction, and thrombocytopenia after ocrelizumab administration. The incidence of side effects also varies from study to study.

Real-World Application Precautions

Ocrelizumab is an effective treatment for MS, but there is a potential risk of side effects, such as infections. 1 , 3 , 2 If you are considering taking ocrelizumab, it is important to discuss your situation with your doctor and choose a treatment plan that is right for you.

Limitations of Current Research

The long-term safety and efficacy of ocrelizumab are not yet fully understood. 6 , 5 Further long-term studies are needed.

Future Research Directions

Research is needed to investigate the long-term safety and efficacy of ocrelizumab, as well as the mechanisms by which side effects occur. 6 , 5 It is also important to develop methods for identifying patients who will respond well to ocrelizumab and those who will not.

Conclusion

Ocrelizumab is an effective treatment for MS, but there is a potential risk of side effects, such as infections. 1 , 3 , 2 If you are considering taking ocrelizumab, it is important to discuss your situation with your doctor and choose a treatment plan that is right for you. The long-term safety and efficacy of ocrelizumab are not yet fully understood. 6 , 5 Further long-term studies are needed.

Literature analysis of 6 papers
Positive Content
6
Neutral Content
0
Negative Content
0
Article Type
0
0
0
3
5
1.

Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients.

Author: ProcklVictoria, NickelFlorian T, UtzKathrin S, FröhlichKilian, EngelhornTobias, HilzMax-Josef, LeeDe-Hyung, LinkerRalf A, HuhnKonstantin

Ocrelizumab efficacy
Adverse events

Ocrelizumab is a monoclonal antibody approved for treating multiple sclerosis (MS). While pivotal trials showed its efficacy and safety, real-world data on adverse events are limited. This study aims to investigate the short-term tolerability of ocrelizumab in a real-world setting.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

3.

Management of MS Patients Treated With Daclizumab - a Case Series of 267 Patients.

Author: RommerPaulus S, BergerKlaus, EllenbergerDavid, FneishFiras, SimbrichAlexandra, StahmannAlexander, ZettlUwe K

Multiple sclerosis treatment
Brain inflammation

This study examines the therapy management of patients who received daclizumab, a drug that was previously used to treat multiple sclerosis (MS), after it was withdrawn from the market due to safety concerns. The study found that most patients switched to other treatments shortly after discontinuing daclizumab.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Language : English

5.

An update on new and emerging therapies for relapsing-remitting multiple sclerosis.

Author: Weinstock-GuttmanBianca

Improved adherence
MS treatment
Oral administration
Progressive multifocal leukoencephalopathy
Side effects

Disease-modifying therapies (DMTs) have been used for over a decade to treat relapsing-remitting multiple sclerosis (RRMS). While first-line DMTs have shown only partial benefits and often have inadequate patient adherence, newer DMTs offer more efficacious treatment, more favorable methods of administration, and lower infusion frequencies, which may improve adherence and clinical outcomes.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

6.

Emerging therapies in relapsing-remitting multiple sclerosis.

Author: MarriottJames J, O'ConnorPaul W

Convenience
RRMS treatment
Fatal complications
Side effects

This study reviewed the current and future of disease-modifying therapies (DMTs) for relapsing-remitting multiple sclerosis (RRMS). The researchers highlighted the need to weigh the convenience of oral DMTs against the relative inconvenience but long-term safety of current first-line injectable therapies.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.